Effect of an enteral diet supplemented with a specific blend of amino acid on plasma and muscle protein synthesis in ICU patients

Clinical Nutrition

Volumn 26, Issue 1, 2007, Pages 30-40

  Mansoor, Odile ^a   Breuillé, Denis ^b   Béchereau, Fabienne ^c   Buffière, Caroline ^b   Pouyet, Corinne ^b   Beaufrère, Bernard ^d   Vuichoud, Jacques ^b   Van't Of, Martin ^b   Obled, Christiane ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c CEMAGREF   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Amino acid supplementation; Plasma and muscle protein synthesis; Polytrauma patients

Indexed keywords

3 METHYLHISTIDINE; ALANINE; ALBUMIN; AMINO ACID; ASPARAGINE; ASPARTIC ACID; C REACTIVE PROTEIN; CYSTEINE; FIBRINOGEN; HAPTOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; LEUCINE; MUSCLE PROTEIN; OROSOMUCOID; PLASMA PROTEIN; SERINE; THREONINE; TUMOR NECROSIS FACTOR;

ACUTE PHASE RESPONSE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; MALE; NITROGEN BALANCE; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; TRAUMATOLOGY; URINARY EXCRETION;

EID: 33846811043     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.07.007     Document Type: Article

References (37)

1. Plank L.D., and Hill G.L. Sequential metabolic changes following induction of systemic inflammatory response in patients with severe sepsis or major blunt trauma. World J Surg 24 (2000) 630-638
2. 2+-activated and ubiquitin-roteasome proteolytic pathways. J Clin Invest 97 (1996) 1610-1617
3. 2+-activated and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci 93 (1996) 2714-2718
4. Mansoor O., Cayol M., Gachon P., et al. Albumin and fibrinogen syntheses increase while muscle protein synthesis decreases in head-injured patients. Am J Physiol.Endocrinol Metab 273 (1997) E898-E902
5. Breuillé D., Arnal M., Rambourdin F., Bayle G., Levieux D., and Obled C. Sustained modifications of protein metabolism in various tissues in a rat model of long-lasting sepsis. Clin Sci 94 (1998) 413-423
6. Ishibashi N., Plank L.D., Sando K., and Hill G.L. Optimal protein requirements during the first 2 weeks after the onset of critical illness. Crit Care Med 26 (1998) 1529-1535
7. Reeds P.J., Fjeld C.R., and Jahoor F. Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?. J Nutr 124 (1994) 906-910
8. Breuillé D., Béchereau F., Buffière C., Denis P., Pouyet C., and Obled C. Beneficial effect of amino acid supplementation, especially cysteine, on body nitrogen economy in septic rats. Clin Nutr 25 (2006) 634-642
9. Malmezat T., Breuillé D., Pouyet C., Patureau Mirand P., and Obled C. Metabolism of cysteine is modified during the acute phase of sepsis in rats. J Nutr 128 (1998) 97-105
10. Malmezat T., Breuillé D., Capitan P., Patureau Mirand P., and Obled C. Glutathione turnover is increased during the acute phase of sepsis in rats. J Nutr 130 (2000) 1239-1246
11. Obled C., Papet I., and Breuillé D. Sulfur-containing amino acids and glutathione in diseases. In: Cynober L.A. (Ed). Metabolic and therapeutic aspects of amino acids in clinical nutrition. 3rd ed (2004), CRC Press, Boca Raton, FL 667-687
12. Hammond C.L., Lee T.K., and Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 34 (2001) 946-954
13. Meister A. Glutathione deficiency produced by inhibition of its synthesis and its reversal; applications in research and therapy. Pharmacol Ther 51 (1991) 155-194
14. Malmezat T., Breuillé D., Pouyet C., et al. Methionine transsulfuration is increased during sepsis in rats. Am J Physiol Endocrinol Metab 279 (2000) E1391-E1397
15. Dohrman A., Miyata S., Gallup M., et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochem Biophys Acta 1406 (1998) 251-259
16. Faure M., Moënnoz D., Montigon F., Mettraux C., Breuillé D., and Ballèvre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr 135 (2005) 486-491
17. Le Gall J.R., Lemeshow S., and Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 270 (1993) 2957-2963
18. Cayol M., Boirie Y., Rambourdin F., et al. Influence of protein intake on whole body and splanchnic leucine kinetics in humans. Am J Physiol Endocrinol Metab 272 (1996) E584-E591
19. Arnold J., Campbell I.T., Samuels T.A., et al. Increased whole body protein breakdown predominates over increased protein synthesis in multiple organ failure. Clin Sci 84 (1993) 655-661
20. Yu Y.M., Ryan C.M., Burke J.F., Tompkins R.G., and Young V.R. Relations among arginine, citrulline, ornithine, and leucine kinetics in adult burn patients. Am J Clin Nutr 62 (1995) 960-968
21. Essén P., McNurlan M.A., Gamrin L., et al. Tissue protein synthesis rates in critically ill patients. Crit Care Med 26 (1998) 92-100
22. Heys S.D., Park K.G.M., McNurlan M.A., et al. Protein synthesis rates in colon and liver stimulation by gastrointestinal pathologies. Gut 33 (1992) 976-981
23. Breuillé D., Rosé F., Arnal M., Melin C., and Obled C. Sepsis modifies the contribution of different organs to whole-body protein synthesis in rats. Clin Sci 86 (1994) 663-669
24. Vary T.C., and Kimball S.R. Regulation of hepatic protein synthesis in chronic inflammation and sepsis. Am J Physiol Cell Physiol 262 (1992) C445-C452
25. Thompson C., Blumenstock F.A., Saba T.M., et al. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest 84 (1989) 1226-1235
26. Shaw J.H., Widbore M., and Wolfe R.R. Whole body protein kinetics in severely septic patients. The response to glucose and total parenteral nutrition. Ann Surg 205 (1987) 288-294
27. Gogos C.A., Drosou E., Bassaris H.P., and Skoutelis A. Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181 (2000) 176-180
28. Remick D.G. Cytokine therapeutics for the treatment of sepsis: why has nothing worked?. Curr Pharm Des 9 (2003) 75-82
29. Zamir O., Hasselgren P.O., Kunkel S.L., Frederick J., Higashiguchi T., and Fischer J.E. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 127 (1992) 170-174
30. Zamir O., O'Brien W., Thompson R., Bloedow D.C., Fischer J.E., and Hasselgren P.O. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int J Biochem 26 (1994) 943-950
31. Vary T.C. Regulation of skeletal muscle protein turnover during sepsis. Curr Opin Clin Nutr Metab Care 1 (1998) 217-224
32. Shibanuma M., Kuroki T., and Nose K. Inhibition by N-acetyl-l-cysteine of interleukin-6 mRNA induction and induction and activation of NFκB by tumor necrosis factor α in a mouse fibroblastic cell line, Balb/3T3. Febs Lett 353 (1994) 62-66
33. Antonicelli F., Parmentier M., Drost E.M., et al. Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappa B nuclear binding in alveolar epithelial cells. Free Radic Biol Med 32 (2002) 492-502
34. Peristeris P., Clark B.D., Gatti S., et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 140 (1992) 390-399
35. Bakker J., Zhang H., Depierreux M., Van Asbeck S., and Vincent J.L. Effects of N-acetyl-cysteine in endotoxic shock. J Crit Care 9 (1994) 236-243
36. Spapen H., Zhang H.B., Demanet C., Vleminckx W., Vincent J.L., and Huyghens L. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock?. Chest 113 (1998) 1616-1624
37. Molnar Z., MacKinnon K.L., Shearer E., Lowe D., and Watson I.D. The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients. Intens Care Med 24 (1998) 230-235